Physician profile
David V Spurlin
NPI 1679500573
$13,336.36
in general payments reported to CMS, 2019-2025
45 companies · $2,501 in 2025
The $2,501 reported for 2025 was more than what 81% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,222 · 2020: $1,072 · 2021: $1,352 · 2022: $2,055 · 2023: $1,931 · 2024: $2,204 · 2025: $2,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,147 · Education: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,147.30 |
| Education | $488.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,187.48 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Genzyme Corporation | $1,627.77 | 2019-2025 | |
| Abbvie INC. | $1,620.86 | 2019-2025 | Rinvoq, Skyrizi, Botox |
| Regeneron Healthcare Solutions, INC. | $1,257.88 | 2019-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $695.40 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $669.55 | 2019-2025 | Ilumya |
| Pfizer INC. | $624.85 | 2019-2025 | |
| Amgen INC. | $575.18 | 2019-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $374.42 | 2019-2025 | Aklief, Nemluvio, Oracea |
| Leo Pharma INC. | $371.08 | 2019-2025 | Adbry, Anzupgo |
| Almirall LLC | $356.55 | 2019-2025 | Klisyri |
| Lilly USA, LLC | $355.38 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Ucb, INC. | $288.13 | 2019-2023 | Cimzia, Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $210.78 | 2022-2025 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $201.83 | 2019-2024 | Jublia, Arazlo |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Spurlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.